<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03628703</url>
  </required_header>
  <id_info>
    <org_study_id>CIN001 - TAA2018</org_study_id>
    <nct_id>NCT03628703</nct_id>
  </id_info>
  <brief_title>Response Inhibition in Tourette Syndrome</brief_title>
  <official_title>Using Repetitive Transcranial Magnetic Stimulation to Modulate Response Inhibition in Tourette Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have
      difficulties controlling unwanted movements. The ability to control the motor system involves
      the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use
      Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability
      to stop an unwanted action in a behavior task (stop signal task).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2019</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stop Signal Reaction Time (SSRT)</measure>
    <time_frame>Immediately after Repetitive Transcranial Magnetic Stimulation</time_frame>
    <description>SSRT measured from stop signal task performance</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Tourette Syndrome</condition>
  <arm_group>
    <arm_group_label>Repetitive TMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Repetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Repetitive TMS</intervention_name>
    <description>Repetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation over the right Pre-supplementary Motor Area</description>
    <arm_group_label>Repetitive TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tourette Syndrome

        Exclusion Criteria:

          -  Autism spectrum disorder

          -  Mood disorder

          -  Epilepsy

          -  Implanted medical device (e.g. pacemaker, shunt, pumps)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steve W. Wu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hannah Jackson</last_name>
    <phone>513-803-2670</phone>
    <email>hannah.jackson@cchmc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Steve W. Wu, MD</last_name>
    <phone>513-636-4222</phone>
    <email>tics@cchmc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Jackson</last_name>
      <phone>513-803-2670</phone>
      <email>hannah.jackson@cchmc.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>May 3, 2019</last_update_submitted>
  <last_update_submitted_qc>May 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tourette Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

